QQ客服 官方微博 反馈留言

	Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy
	Gu, Fei-fei; Zhang, Yong; Liu, Yang-yang; Hong, Xiao-hua; Liang, Jin-yan; Tong, Fan; Yang, Jing-song; Liu, Li
	2016
关键词	NSCLC Lung adenocarcinoma Oncogenic drivers SPTBN1-ALK c-Met HER-2 Crizotinib Chemotherapy Radiotherapy
ISSN号	1756-8722
URL标识	查看原文
语种	英语
出处	JOURNAL OF HEMATOLOGY & ONCOLOGY
DOI标识	10.1186/s13045-016-0296-8
卷号	9
收录类别	SCIE
内容类型	其他
URI标识	http://www.corc.org.cn/handle/1471x/4104199
专题	武汉大学
推荐引用方式 GB/T 7714	Gu, Fei-fei,Zhang, Yong,Liu, Yang-yang,et al. Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy. 2016-01-01.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。